Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Thursday broker round-up

Thu, 06th May 2021 13:43

(Sharecast News) - National Grid: Berenberg upgrades to buy with a target price of 1,100p.



Hiscox: Berenberg reiterates hold with a target price of 973p.

ITV: Berenberg reiterates hold with a target price of 117p.

SIG: Canaccord reiterates hold with a target price of 45p.

Quixant: Canaccord reiterates buy with a target price of 200p.

ITV: JP Morgan reiterates overweight with a target price of 170p.

Tritax Big Box: Barclays reiterates equal weight with a target price of 205p.

UDG Healthcare: Barclays reiterates overweight with a target price of 975p.

Compass Group: Deutsche Bank reiterates buy with a target price of 1720p.

CVS: Liberum reiterates hold with a target price of 2,200p.

AstraZeneca: Liberum reiterates buy with a target price of 9,220p.

Gateley: Peel Hunt reiterates add with a target price of 200p.

Melrose: Peel Hunt reiterates buy with a target price of 300p.

Prudential: Credit Suisse reiterates outperform with a target price of 1,750p.

Next: Numis reiterates add with a target price of 7,200p.

Melrose: Numis reiterates add with a target price of 205p.

Related Shares

More News
Today 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump...

Today 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover ta...

Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln *

Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.